Perhaps venture capital should given incentives. If there are breakthroughs coming they'll only happen through funded companies. The other possibility, which

Perhaps venture capital should given incentives. If there are breakthroughs coming they'll only happen through funded companies. The other possibility, which I'm sure is unpopular to utter around here, is that there are no cancer breakthroughs to be made in a reasonable time frame and the capital markets and big pharma are behaving quite rationally. Despite all the billions poured into cancer research over the last 30 years the advancements seem pretty weak, from my limited understanding. Apparently they use eight years cancer free as the mark to declare you cured. But then people often relapse and drop dead young not so long after that. At some point it might make sense to admit pouring more money into drug and treatment research is detracting from other pursuits. You could probably make a much bigger dent in cancer by studying preventive nutrition and how to make it widespread.